Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q01082 (SPTB2_HUMAN)

Last modified July 7, 2009. Version 99. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Spectrin beta chain, brain 1
Alternative name(s):
    Spectrin, non-erythroid beta chain 1
    Beta-II spectrin
    Fodrin beta chain
Gene names
Name: SPTBN1
Synonyms: SPTB2
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length2364 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane.

Subunit structure

Like erythrocyte spectrin, the spectrin-like proteins are capable to form dimers which can further associate to tetramers. The short form cannot bind to the axonal protein fodaxin. Interacts with ANK2. Ref.7

Subcellular location

Cytoplasmcytoskeleton By similarity. CytoplasmmyofibrilsarcomereM-band By similarity. Note: Colocalizes with ANK2 in a distinct intracellular compartment of neonatal cardiomyocytes By similarity.

Isoform 2: Cell membrane; Peripheral membrane protein; Cytoplasmic side By similarity.

Tissue specificity

Isoform 2 is present in brain, lung and kidney (at protein level). Ref.2

Post-translational modification

Isoform 2 is phosphorylated on Ser-8 and Ser-10 By similarity.

Sequence similarities

Belongs to the spectrin family.

Contains 2 CH (calponin-homology) domains.

Contains 1 PH domain.

Contains 17 spectrin repeats.

Ontologies

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform Long (identifier: Q01082-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform Short (identifier: Q01082-2)

The sequence of this isoform differs from the canonical sequence as follows:
     2141-2168: MAETVDTSEMVNGATEQRTSSKESSPIP → VSYRSQTYQNYKNFNSRRTASDQPWSGL
     2169-2364: Missing.
Isoform 2 (identifier: Q01082-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1-49: MTTTVATDYD...FERSRIKALA → MELQRTSSIS...QLEGRFKQLQ
     2141-2225: MAETVDTSEM...KASSRSWHNV → VSYRSQTYQNYKNFNSRRTASDQPWSGL
     2226-2364: Missing.
Note: Phosphorylated on Ser-8 (By similarity), Ser-10 and Ser-14.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 23642364Spectrin beta chain, brain 1
PRO_0000073461

Regions

Domain1 – 275275Actin-binding
Domain54 – 158105CH 1
Domain173 – 275103CH 2
Repeat276 – 384109Spectrin 1
Repeat385 – 498114Spectrin 2
Repeat499 – 608110Spectrin 3
Repeat609 – 714106Spectrin 4
Repeat715 – 819105Spectrin 5
Repeat820 – 925106Spectrin 6
Repeat926 – 1032107Spectrin 7
Repeat1033 – 1139107Spectrin 8
Repeat1140 – 1245106Spectrin 9
Repeat1246 – 1350105Spectrin 10
Repeat1351 – 1462112Spectrin 11
Repeat1463 – 1562100Spectrin 12
Repeat1563 – 1668106Spectrin 13
Repeat1669 – 1775107Spectrin 14
Repeat1776 – 1881106Spectrin 15
Repeat1882 – 1987106Spectrin 16
Repeat1988 – 2133146Spectrin 17
Domain2197 – 2307111PH
Region1563 – 2093531Interaction with ANK2

Amino acid modifications

Modified residue9991Phosphothreonine By similarity
Modified residue18051Phosphotyrosine By similarity
Modified residue19181Phosphoserine By similarity
Modified residue21021Phosphoserine Ref.9 Ref.10 Ref.11 Ref.13 Ref.14 Ref.15
Modified residue21151Phosphoserine By similarity
Modified residue21281Phosphoserine Ref.10 Ref.8
Modified residue21381Phosphoserine Ref.10 Ref.14 Ref.15 Ref.8
Modified residue21591Phosphothreonine Ref.15
Modified residue21601Phosphoserine Ref.15
Modified residue21641Phosphoserine Ref.13 Ref.15
Modified residue21651Phosphoserine Ref.15 Ref.8
Modified residue21691Phosphoserine Ref.9 Ref.13 Ref.15 Ref.8 Ref.12
Modified residue21871Phosphothreonine Ref.15
Modified residue21951Phosphothreonine By similarity
Modified residue23281Phosphothreonine Ref.15
Modified residue23411Phosphoserine Ref.15
Glycosylation23241O-linked (GlcNAc) By similarity

Natural variations

Alternative sequence1 – 4949MTTTV…IKALA → MELQRTSSISGPLSPAYTGQ VPYNYNQLEGRFKQLQ in isoform 2.
VSP_026054
Alternative sequence2141 – 222585MAETV…SWHNV → VSYRSQTYQNYKNFNSRRTA SDQPWSGL in isoform 2.
VSP_026055
Alternative sequence2141 – 216828MAETV…SSPIP → VSYRSQTYQNYKNFNSRRTA SDQPWSGL in isoform Short.
VSP_000720
Alternative sequence2169 – 2364196Missing in isoform Short.
VSP_000721
Alternative sequence2226 – 2364139Missing in isoform 2.
VSP_026056
Natural variant14111D → H: dbSNP rs1052790. Ref.2 Ref.1
VAR_032641

Experimental info

Sequence conflict5831R → W in BAD92985. Ref.3

Secondary structure

.................... 2364
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform Long [UniParc].

Last modified October 17, 2006. Version 2.
Checksum: 1770C3B0EB07B892

FASTA2,364274,609
        10         20         30         40         50         60 
MTTTVATDYD NIEIQQQYSD VNNRWDVDDW DNENSSARLF ERSRIKALAD EREAVQKKTF 

        70         80         90        100        110        120 
TKWVNSHLAR VSCRITDLYT DLRDGRMLIK LLEVLSGERL PKPTKGRMRI HCLENVDKAL 

       130        140        150        160        170        180 
QFLKEQRVHL ENMGSHDIVD GNHRLTLGLI WTIILRFQIQ DISVETEDNK EKKSAKDALL 

       190        200        210        220        230        240 
LWCQMKTAGY PNVNIHNFTT SWRDGMAFNA LIHKHRPDLI DFDKLKKSNA HYNLQNAFNL 

       250        260        270        280        290        300 
AEQHLGLTKL LDPEDISVDH PDEKSIITYV VTYYHYFSKM KALAVEGKRI GKVLDNAIET 

       310        320        330        340        350        360 
EKMIEKYESL ASDLLEWIEQ TIIILNNRKF ANSLVGVQQQ LQAFNTYRTV EKPPKFTEKG 

       370        380        390        400        410        420 
NLEVLLFTIQ SKMRANNQKV YMPREGKLIS DINKAWERLE KAEHERELAL RNELIRQEKL 

       430        440        450        460        470        480 
EQLARRFDRK AAMRETWLSE NQRLVSQDNF GFDLPAVEAA TKKHEAIETD IAAYEERVQA 

       490        500        510        520        530        540 
VVAVARELEA ENYHDIKRIT ARKDNVIRLW EYLLELLRAR RQRLEMNLGL QKIFQEMLYI 

       550        560        570        580        590        600 
MDWMDEMKVL VLSQDYGKHL LGVEDLLQKH TLVEADIGIQ AERVRGVNAS AQKFATDGEG 

       610        620        630        640        650        660 
YKPCDPQVIR DRVAHMEFCY QELCQLAAER RARLEESRRL WKFFWEMAEE EGWIREKEKI 

       670        680        690        700        710        720 
LSSDDYGKDL TSVMRLLSKH RAFEDEMSGR SGHFEQAIKE GEDMIAEEHF GSEKIRERII 

       730        740        750        760        770        780 
YIREQWANLE QLSAIRKKRL EEASLLHQFQ ADADDIDAWM LDILKIVSSS DVGHDEYSTQ 

       790        800        810        820        830        840 
SLVKKHKDVA EEIANYRPTL DTLHEQASAL PQEHAESPDV RGRLSGIEER YKEVAELTRL 

       850        860        870        880        890        900 
RKQALQDTLA LYKMFSEADA CELWIDEKEQ WLNNMQIPEK LEDLEVIQHR FESLEPEMNN 

       910        920        930        940        950        960 
QASRVAVVNQ IARQLMHSGH PSEKEIKAQQ DKLNTRWSQF RELVDRKKDA LLSALSIQNY 

       970        980        990       1000       1010       1020 
HLECNETKSW IREKTKVIES TQDLGNDLAG VMALQRKLTG MERDLVAIEA KLSDLQKEAE 

      1030       1040       1050       1060       1070       1080 
KLESEHPDQA QAILSRLAEI SDVWEEMKTT LKNREASLGE ASKLQQFLRD LDDFQSWLSR 

      1090       1100       1110       1120       1130       1140 
TQTAIASEDM PNTLTEAEKL LTQHENIKNE IDNYEEDYQK MRDMGEMVTQ GQTDAQYMFL 

      1150       1160       1170       1180       1190       1200 
RQRLQALDTG WNELHKMWEN RQNLLSQSHA YQQFLRDTKQ AEAFLNNQEY VLAHTEMPTT 

      1210       1220       1230       1240       1250       1260 
LEGAEAAIKK QEDFMTTMDA NEEKINAVVE TGRRLVSDGN INSDRIQEKV DSIDDRHRKN 

      1270       1280       1290       1300       1310       1320 
RETASELLMR LKDNRDLQKF LQDCQELSLW INEKMLTAQD MSYDEARNLH SKWLKHQAFM 

      1330       1340       1350       1360       1370       1380 
AELASNKEWL DKIEKEGMQL ISEKPETEAV VKEKLTGLHK MWEVLESTTQ TKAQRLFDAN 

      1390       1400       1410       1420       1430       1440 
KAELFTQSCA DLDKWLHGLE SQIQSDDYGK DLTSVNILLK KQQMLENQME VRKKEIEELQ 

      1450       1460       1470       1480       1490       1500 
SQAQALSQEG KSTDEVDSKR LTVQTKFMEL LEPLNERKHN LLASKEIHQF NRDVEDEILW 

      1510       1520       1530       1540       1550       1560 
VGERMPLATS TDHGHNLQTV QLLIKKNQTL QKEIQGHQPR IDDIFERSQN IVTDSSSLSA 

      1570       1580       1590       1600       1610       1620 
EAIRQRLADL KQLWGLLIEE TEKRHRRLEE AHRAQQYYFD AAEAEAWMSE QELYMMSEEK 

      1630       1640       1650       1660       1670       1680 
AKDEQSAVSM LKKHQILEQA VEDYAETVHQ LSKTSRALVA DSHPESERIS MRQSKVDKLY 

      1690       1700       1710       1720       1730       1740 
AGLKDLAEER RGKLDERHRL FQLNREVDDL EQWIAEREVV AGSHELGQDY EHVTMLQERF 

      1750       1760       1770       1780       1790       1800 
REFARDTGNI GQERVDTVNH LADELINSGH SDAATIAEWK DGLNEAWADL LELIDTRTQI 

      1810       1820       1830       1840       1850       1860 
LAASYELHKF YHDAKEIFGR IQDKHKKLPE ELGRDQNTVE TLQRMHTTFE HDIQALGTQV 

      1870       1880       1890       1900       1910       1920 
RQLQEDAARL QAAYAGDKAD DIQKRENEVL EAWKSLLDAC ESRRVRLVDT GDKFRFFSMV 

      1930       1940       1950       1960       1970       1980 
RDLMLWMEDV IRQIEAQEKP RDVSSVELLM NNHQGIKAEI DARNDSFTTC IELGKSLLAR 

      1990       2000       2010       2020       2030       2040 
KHYASEEIKE KLLQLTEKRK EMIDKWEDRW EWLRLILEVH QFSRDASVAE AWLLGQEPYL 

      2050       2060       2070       2080       2090       2100 
SSREIGQSVD EVEKLIKRHE AFEKSAATWD ERFSALERLT TLELLEVRRQ QEEEERKRRP 

      2110       2120       2130       2140       2150       2160 
PSPEPSTKVS EEAESQQQWD TSKGEQVSQN GLPAEQGSPR MAETVDTSEM VNGATEQRTS 

      2170       2180       2190       2200       2210       2220 
SKESSPIPSP TSDRKAKTAL PAQSAATLPA RTQETPSAQM EGFLNRKHEW EAHNKKASSR 

      2230       2240       2250       2260       2270       2280 
SWHNVYCVIN NQEMGFYKDA KTAASGIPYH SEVPVSLKEA VCEVALDYKK KKHVFKLRLN 

      2290       2300       2310       2320       2330       2340 
DGNEYLFQAK DDEEMNTWIQ AISSAISSDK HEVSASTQST PASSRAQTLP TSVVTITSES 

      2350       2360 
SPGKREKDKE KDKEKRFSLF GKKK 

« Hide

Isoform Short.

Checksum: 34F9C77E47199043
Show »

FASTA2,168253,091
Isoform 2.

Checksum: 2CA864D7AAC0182C
Show »

FASTA2,155251,397

References

« Hide 'large scale' references
[1]"Characterization of human brain cDNA encoding the general isoform of beta-spectrin."
Hu R.J., Watanabe M., Bennett V.
J. Biol. Chem. 267:18715-18722(1992) [PubMed: 1527002] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), VARIANT HIS-1411.
Tissue: Brain.
[2]"A novel isoform of beta-spectrin II localizes to cerebellar Purkinje-cell bodies and interacts with neurofibromatosis type 2 gene product schwannomin."
Chen Y., Yu P., Lu D., Tagle D.A., Cai T.
J. Mol. Neurosci. 17:59-70(2001) [PubMed: 11665863] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, VARIANT HIS-1411.
[3]Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F.
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
Tissue: Brain.
[4]"Generation and annotation of the DNA sequences of human chromosomes 2 and 4."
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. expand/collapse author list , Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., Wilson R.K.
Nature 434:724-731(2005) [PubMed: 15815621] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[5]"Cloning of a portion of the chromosomal gene and cDNA for human beta-fodrin, the nonerythroid form of beta-spectrin."
Chang J.G., Scarpa A., Eddy R.L., Byers M.G., Harris A.S., Morrow J.S., Watkins P., Shows T.B., Forget B.G.
Genomics 17:287-293(1993) [PubMed: 8406479] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 293-1544.
[6]"Identification of a novel C-terminal variant of betaII spectrin: two isoforms of betaII spectrin have distinct intracellular locations and activities."
Hayes N.V.L., Scott C., Heerkens E., Ohanian V., Maggs A.M., Pinder J.C., Kordeli E., Baines A.J.
J. Cell Sci. 113:2023-2034(2000) [PubMed: 10806113] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 2087-2168 (ISOFORM SHORT).
Tissue: Skeletal muscle.
[7]"Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes."
Mohler P.J., Yoon W., Bennett V.
J. Biol. Chem. 279:40185-40193(2004) [PubMed: 15262991] [Abstract]
Cited for: INTERACTION WITH ANK2.
[8]"Large-scale characterization of HeLa cell nuclear phosphoproteins."
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2128; SER-2138; SER-2165 AND SER-2169, MASS SPECTROMETRY.
Tissue: Epithelium.
[9]"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."
Kim J.-E., Tannenbaum S.R., White F.M.
J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102 AND SER-2169, MASS SPECTROMETRY.
[10]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102; SER-2128 AND SER-2138, MASS SPECTROMETRY.
Tissue: Epithelium.
[11]"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.
J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102, MASS SPECTROMETRY.
Tissue: Epithelium.
[12]"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.
Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2169, MASS SPECTROMETRY.
[13]"Phosphoproteome of resting human platelets."
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A.
J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102; SER-2164 AND SER-2169, MASS SPECTROMETRY.
Tissue: Platelet.
[14]"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102 AND SER-2138, MASS SPECTROMETRY.
[15]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102; SER-2138; THR-2159; SER-2160; SER-2164; SER-2165; SER-2169; THR-2187; THR-2328 AND SER-2341, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10 AND SER-14 (ISOFORM 3), MASS SPECTROMETRY.
[16]Colinge J., Superti-Furga G., Bennett K.L.
Submitted (OCT-2008) to UniProtKB
Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[17]"Crystal structure of a calponin homology domain."
Carugo K.D., Banuelos S., Saraste M.
Nat. Struct. Biol. 4:175-179(1997) [PubMed: 9164454] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 173-280.
[18]"Structural comparisons of calponin homology domains: implications for actin binding."
Banuelos S., Saraste M., Carugo K.D.
Structure 6:1419-1431(1998) [PubMed: 9817844] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS) OF 173-281.
+Additional computationally mapped references.

Cross-references

Sequence databases

M96803 mRNA. Translation: AAA60580.1.
AF327441 mRNA. Translation: AAO15362.1.
AB209748 mRNA. Translation: BAD92985.1. Different initiation.
AC093110 Genomic DNA. Translation: AAY24229.1.
AC092839 Genomic DNA. No translation available.
S65762 mRNA. Translation: AAB28324.1.
AJ005694 mRNA. Translation: CAA06678.1.
AJ238723 Genomic DNA. Translation: CAB91088.1.
IPIIPI00005614.
IPI00328230.
IPI00333015.
PIRA44159.
A47213.
RefSeqNP_003119.2.
NP_842565.2.
UniGeneHs.503178
Hs.705692

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
1AA2X-ray2.00A173-280[»]
1BKRX-ray1.10A172-280[»]
3EDVX-ray1.95A/B1697-2015[»]
SMRQ01082. Positions 2200-2305.
ModBaseSearch...

Protein-protein interaction databases

IntActQ01082. 19 interactions.

PTM databases

PhosphoSiteQ01082.

Proteomic databases

PRIDEQ01082.

Genome annotation databases

EnsemblENSG00000115306. Homo sapiens. [Contig view]
GeneID6711.
KEGGhsa:6711.
UCSCuc002rxu.1. human.
uc002rxx.1. human.

Organism-specific databases

GeneCardsGC02P054596.
H-InvDBHIX0002055.
HGNCHGNC:11275. SPTBN1.
HPAHPA012685.
HPA013149.
MIM182790. gene.
PharmGKBPA36104.
GenAtlasSearch...

Phylogenomic databases

HOVERGENQ01082.

Enzyme and pathway databases

Pathway_Interaction_DBtgfbrpathway. TGF-beta receptor signaling.

Gene expression databases

ArrayExpressQ01082.
BgeeQ01082.
CleanExHS_SPTBN1.
GermOnlineENSG00000115306. Homo sapiens.

Family and domain databases

InterProIPR001589. Actinin_actin-bd_CS.
IPR001715. Calponin_act_bd.
IPR011993. PH_type.
IPR001849. Pleckstrin_homology.
IPR018159. Spectrin/alpha-actinin.
IPR016343. Spectrin_bsu.
IPR001605. Spectrin_PH.
IPR002017. Spectrin_repeat.
[Graphical view]
Gene3DG3DSA:1.10.418.10. Calponin-homology. 2 hits.
G3DSA:2.30.29.30. PH_type. 1 hit.
PfamPF00307. CH. 2 hits.
PF00169. PH. 1 hit.
PF00435. Spectrin. 17 hits.
[Graphical view]
PIRSFPIRSF002297. Spectrin_beta_subunit. 1 hit.
PRINTSPR00683. SPECTRINPH.
SMARTSM00033. CH. 2 hits.
SM00233. PH. 1 hit.
SM00150. SPEC. 17 hits.
[Graphical view]
PROSITEPS00019. ACTININ_1. 1 hit.
PS00020. ACTININ_2. 1 hit.
PS50021. CH. 2 hits.
PS50003. PH_DOMAIN. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio26172.
SOURCESearch...

Entry information

Entry nameSPTB2_HUMAN
AccessionPrimary (citable) accession number: Q01082
Secondary accession number(s): O60837 expand/collapse secondary AC list , Q16057, Q53R99, Q59ER3, Q8IX99
Entry history
Integrated into UniProtKB/Swiss-Prot: November 1, 1997
Last sequence update: October 17, 2006
Last modified: July 7, 2009
This is version 99 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 2

Human chromosome 2: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents